Clinical Trial of AGB101 for Mild Cognitive Impairment

NCT05986721 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Sponsor decision

Conditions

Mild Cognitive Impairment
Prodromal Alzheimer's Disease

Interventions

DRUG: AGB101
DRUG: Placebo

Sponsor

AgeneBio

Collaborators

[object Object]